Driving global change for local impact 

As the world’s only global patient organisation acting on behalf of the 325 million people living with viral hepatitis, the World Hepatitis Alliance advocates for change to realise the global goal of eliminating viral hepatitis by 2030.

For WHA, advocacy is the work we do to influence the policies and actions of governments, international institutions and the private sector, in order to achieve positive changes in the lives of people living with viral hepatitis.

Our advocacy and campaigns build on the insights generated by our programmes and our member organisations around the world. Our advocacy encompasses research development, in-country activities, communications and public campaigning. We provide a huge range of advocacy resources and lead a number of activities to achieve our goal of eliminating viral hepatitis by 2030.


In 2016, the single greatest global commitment in viral hepatitis was made when 194 governments adopted the WHO’s Global Health Sector Strategy (GHSS) on Viral Hepatitis, which sets a goal of eliminating hepatitis B and C as a public health threat by 2030.

The Strategy, which comes as a response to the Sustainable Development Goals, includes ambitious targets and interventions, which, if reached will reduce the number of deaths by 65% and increase treatment rates from 1% to 80%, saving 10 million lives globally by 2030. 

To achieve the elimination of viral hepatitis by 2030, we identified increasing diagnosis as our key focus for 2018 – 2020. The WHO Elimination Strategy calls for a major increase in diagnosis of chronic viral B and C infection; 30%  by 2020 and 90% by 2030. Today, only 11% of those living with viral hepatitis are aware of their diagnosis. Without a massive scale-up in diagnosis, treatment rates will fall and infection rates will rise. Without finding the “Missing Millions” that are yet to be diagnosed and linking them to care, all other efforts will only have marginal success. Our first step is to find them.

Learn more about our Finding the Missing Millions campaign here.


Without fully-funded national plans, countries will not have the resources to scale-up the services needed to eliminate viral hepatitis. Nor will they have the ability to provide treatment and adequate preventative measures. WHA is working to support  governments to find financing solutions while also calling for greater action from global donors.

  • The National Viral Hepatitis Programme Financing Strategy Template is a tool for countries that are facing the challenge of how to fully fund their hepatitis response. It provides guidance on how to adopt a strategic approach to costing, creating the investment case, budgeting, and financing a viral hepatitis programme. It is also an advocacy tool for civil society to use when engaging with their governments around financing.
  • Making the Investment Case:  Eliminating hepatitis B and hepatitis C as public health threats by 2030 would prevent approximately 36 million infections and save 10 million lives globally. The global investment case for viral hepatitis sets out a clear narrative for investing in viral hepatitis and calls for donor action in low and middle income countries if we are to reach elimination.

Find out how you can use WHA financing resources to shape your national policies here.


National governments across the world have committed to World Health Assembly resolutions to address stigma and discrimination, involve civil society in their response to viral hepatitis and use World Hepatitis Day as an opportunity for improving awareness and education. In 2016/2017 we asked civil society to evaluate how their governments are doing in regards to these commitments. The findings were compiled in our ‘Holding Governments Accountable: WHA Civil Society Survey Global Findings Report’. The report highlights that more needs to be done to ensure that stigma and discrimination is addressed and civil society is meaningfully involved in the response. As well as detailing key findings, the report highlights how the results can be used in advocacy efforts.

Read the full Holding Governments Accountable report here.


Improving access to diagnostics and medicines will be essential to achieving the elimination of viral hepatitis by 2030. Currently 89% of those living with viral hepatitis are unaware they have the disease and of those that are aware less than 1% access treatment. If we are to reach the goal of 90% of people being aware of their illness and 80% of people treated by 2030, as set out in the Global Health Sector Strategy on Viral Hepatitis, much needs to be done.

Civil society have a key role to play in this through advocating for improved access but in order to ensure that any advocacy efforts are effective and sustainable it is important to first understand the issues in this area.

Build your knowledge around access to medicines and diagnostics with our range of resources here.


Understanding the impact viral hepatitis has on a patient’s personal and social life is central to combatting this global disease so in 2014, we commissioned a global patient survey to investigate how viral hepatitis C can impact patients’ lives as well examine patients’ experience of care.

This HCV Quest survey revealed a shocking reality and the findings are still being used in global and national patient advocacy to challenge governments and health policy makers to do more to fight viral hepatitis.

It was conducted over six months between July and December 2014, translated into 35 different languages and has been made available online and in hard copy to patient groups and physicians around the world. The findings have been developed and translated into a global report and 22 local country reports.

View the findings and learn how to use them in your advocayc work here